Compare NEOV & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEOV | STIM |
|---|---|---|
| Founded | 2018 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.5M | 120.4M |
| IPO Year | 2022 | 2018 |
| Metric | NEOV | STIM |
|---|---|---|
| Price | $2.17 | $2.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $9.75 | $5.75 |
| AVG Volume (30 Days) | ★ 1.3M | 685.0K |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.25 |
| EPS | N/A | ★ N/A |
| Revenue | $13,332,953.00 | ★ $52,776,000.00 |
| Revenue This Year | $623.96 | $8.63 |
| Revenue Next Year | $344.27 | $9.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 58.22 | N/A |
| 52 Week Low | $1.36 | $0.80 |
| 52 Week High | $7.13 | $3.44 |
| Indicator | NEOV | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 38.29 | 41.69 |
| Support Level | $2.03 | $1.99 |
| Resistance Level | $3.21 | $2.13 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 12.56 | 60.23 |
NeoVolta Inc is engaged in designing, manufacturing, and selling high-end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its marketplace includes the solar industry, installers, new construction homebuilders, home remodelers, and homeowners. Its ESS product portfolio includes the NV14, NV24, NVPlus, NV7600 stand-alone inverter, and the NV16 kW AC hybrid inverter with 24 kW PV input and a 250 kW / 430 kWh C&I system.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.